Kom G D, Schwedhelm E, Nielsen P, Böger R H
Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.
Free Radic Biol Med. 2006 Apr 1;40(7):1194-200. doi: 10.1016/j.freeradbiomed.2005.11.004. Epub 2005 Dec 13.
The hypothesis according to which iron overload could be harmful has been extensively and controversially discussed in the literature. One underlying pathological mechanism may be elevated oxidative stress. Thus, we studied the correlation between hemochromatosis and an established marker of oxidative stress, 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha, iPF2alpha-III, 15-F2t-IsoP). We enrolled 21 patients with hemochromatosis, positive for the homozygous C282Y mutation in the HFE gene, and 21 healthy controls frequency-matched by age and gender in a case-control study design. The objective was to show that iron overload in HFE-related hemochromatosis is associated with increased oxidative stress assessed through 8-iso-PGF(2alpha) urinary excretion, and that oxidative stress is impacted by iron-removal treatment (phlebotomy). Study parameters were transferrin saturation, 8-iso-PGF(2alpha) urine excretion, transferrin, ferritin, serum iron, and vitamins A and E for all participants. Iron concentration in the liver and non-transferrin-bound iron were measured in patients only. We found a significant difference in 8-iso-PGF2alpha in patients (245 [interquartile range 157-348] pg/mg creatinine) compared with controls (128 [106-191] pg/mg creatinine, P = 0.002). Vitamin A was significantly reduced in cases (0.34 [0.25-1.83] microg/ml compared to 3.00 [2.11-3.39] microg/ml, P < 0.001), while vitamin E did not show a significant difference in cases (14.7 [11.5-18.1] microg/ml) compared with controls (14.9 [13.1-19.2] microg/ml, P = 0.52). After phlebotomy treatment and normalization of the iron parameters in the hemochromatosis group, serum vitamin A levels were significantly increased (1.36 [1.08-1.97] microg/ml, P = 0.035 vs. baseline, P < 0.001 vs. controls) and 8-iso-PGF2alpha urinary excretion was lowered to control levels (146 [117-198] pg/mg creatinine, P = 0.38 vs. controls). In our study, HFE-related hemochromatosis was associated with increased oxidative stress and hypovitaminemia A in C282Y homozygotes. The increased oxidative stress was reversible by normalization of the iron load by phlebotomy. Thus, phlebotomy is an effective and adequate means for reducing oxidative stress in these patients.
铁过载可能有害这一假说在文献中已得到广泛且具争议性的讨论。一种潜在的病理机制可能是氧化应激升高。因此,我们研究了血色素沉着症与一种已确立的氧化应激标志物8-异前列腺素F2α(8-iso-PGF2α、iPF2α-III、15-F2t-IsoP)之间的相关性。在一项病例对照研究设计中,我们纳入了21例血色素沉着症患者,这些患者HFE基因的纯合C282Y突变呈阳性,以及21名年龄和性别频率匹配的健康对照者。目的是表明HFE相关血色素沉着症中的铁过载与通过8-异前列腺素F2α尿排泄评估的氧化应激增加相关,并且氧化应激受到铁去除治疗(放血疗法)的影响。研究参数包括所有参与者的转铁蛋白饱和度、8-异前列腺素F2α尿排泄、转铁蛋白、铁蛋白、血清铁以及维生素A和E。仅对患者测量了肝脏中的铁浓度和非转铁蛋白结合铁。我们发现患者的8-异前列腺素F2α(245[四分位间距157 - 348]pg/mg肌酐)与对照组(128[106 - 191]pg/mg肌酐,P = 0.002)相比存在显著差异。病例组中维生素A显著降低(0.34[0.25 - 1.83]μg/ml,而对照组为3.00[2.11 - 3.39]μg/ml,P < 0.001),而病例组中维生素E与对照组(14.9[13.1 - 19.2]μg/ml)相比未显示出显著差异(14.7[11.5 - 18.1]μg/ml,P = 0.52)。在血色素沉着症组进行放血治疗并使铁参数正常化后,血清维生素A水平显著升高(1.36[1.08 - 1.97]μg/ml,与基线相比P = 0.035,与对照组相比P < 0.001),且8-异前列腺素F2α尿排泄降至对照水平(146[117 - 198]pg/mg肌酐,与对照组相比P = 0.38)。在我们的研究中,HFE相关血色素沉着症与C282Y纯合子中氧化应激增加和维生素A缺乏血症相关。通过放血使铁负荷正常化可使增加的氧化应激逆转。因此,放血疗法是降低这些患者氧化应激的一种有效且适当的手段。